PYXS stock pitch - 2022-07-22

Added to YB: 2022-07-22

Pitch date: 2022-07-22

Pyxis Oncology, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors.

Market Cap

$56.1M

Pitch Price

$2.83

Price Target

N/A

Dividend

N/A

EV/EBITDA

0.87

P/E

-0.69

EV/Sales

-3.13

Sector

Biotechnology

A summary for this pitch has not been created yet.